SPOTLIGHT: Terminal patients not entitled to unapproved drugs

The Supreme Court has ruled that terminally ill patients have no constitutional right to gain access to experimental drugs which haven't yet won FDA approval. Advocates had argued that the FDA was violating the legal rights of patients by making them wait until companies complete long clinical trials. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.